High5 with Dr. Igor Grant, MD
High5 with Dr. Igor Grant, MD
Podcast Description
Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
Podcast Insights
Content Themes
The podcast delves into various topics surrounding medicinal cannabis, including its impact on pain management, the role of neuroimaging in understanding substance use, and cardiovascular risks associated with cannabis use, with specific episodes discussing the Cannabis Act in Canada and its implications for the U.S. as well as the relationship between cannabis and driving impairment.
Welcome to High5 with Dr. Igor Grant, Distinguished Professor of Psychiatry and Director of the Center for Medicinal Cannabis Research at UC San Diego. Each month, we’ll take you on a fascinating journey into the evolving world of medicinal cannabis. From groundbreaking research to candid conversations with top scientists and clinicians across the globe. In each episode, Dr. Grant poses five thought-provoking questions to his guest, uncovering their personal journey and unique contributions to the field of medicinal cannabis.
Summary
In episode 8, Drs. Igor Grant and Dale Gieringer discuss Dr. Gieringer’s extensive involvement in cannabis legalization efforts in California, particularly through his work with California NORML. He reflects on the historical context surrounding cannabis laws, the significance of Proposition 215, the first medical marijuana initiative, and the subsequent passage of Proposition 64, which legalized recreational use. Dr. Gieringer emphasizes the need for continued advocacy and research in the field of cannabis, highlighting the challenges and opportunities that lie ahead in harmonizing state and federal regulations.
Takeaways
• Dale Gieringer has been involved in cannabis reform since 1987.
• NORML was founded to advocate for consumer rights regarding marijuana.
• Proposition 215 was the first medical marijuana law in the U.S.
• The medical marijuana movement gained momentum in the 1990s in San Francisco, CA.
• Public support for cannabis legalization has grown significantly over the years.
• Proposition 64 decriminalized marijuana and reduced felony arrests.
• Research on cannabis remains limited due to federal restrictions.
• The medical ID card program in California is underutilized.
• There is a need for better education among cannabis dispensary staff.
• Future cannabis policy should focus on harmonizing state and federal laws.
Chapters
00:00 – Intro
01:02 – Dr. Geringer’s Background
05:54 – What is NORML and CalNORML?
07:05 – The Role of NORML in Cannabis Legalization
10:14 – The Journey of Proposition 215
13:29 – Dr. Tod Mikuriya’s Role
16:35 – Dennis Peron and San Francisco’s Medical Marijuana Initiative in 1991
18:27 – San Francisco’s Patient’s Buyers Club & Prop 215
21:04 – Ballot Measures in California & Prop 215
23:20 – Rescheduling Cannabis
24:24 – Prop 19, Prop 64, & Adult Use Legalization
35:35 – Future Directions for Cannabis Legislation
37:10 – The State of Medical Cannabis in California
42:50 – Outro
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.